|Last Price||Today's Change||52-Week Range||Trading Volume|
|55.82||0.69 (+1.25%)||51.88 - 71.60||6.9 million (Below Avg)|
Market data as of 4:00PM 10/02/15. Quotes are delayed by at least 15 min.
AbbVie Demonstrates Commitment to Hepatitis C Patients with New Data on VIEKIRA PAK™ (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) and Ongoing Clinical Development Program at The Liver Meeting® 2015
10/01/2015 1:02 PM ET
AbbVie to Advance Once-Daily ABT-494 to Phase 3 in Rheumatoid Arthritis by Year-End
09/25/2015 7:13 AM ET